Novo Holdings A/S - 09 Nov 2021 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role
10%+ Owner
Signature
/S/Barbara Fiorini Due, General Counsel of Novo Holdings A/S
Issuer symbol
IOBT
Transactions as of
09 Nov 2021
Net transactions value
+$4,550,000
Form type
4
Filing time
10 Nov 2021, 18:04:50 UTC
Previous filing
04 Nov 2021
Next filing
03 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IOBT COMMON STOCK Conversion of derivative security +2,952,932 2,952,932 09 Nov 2021 Direct F1
transaction IOBT COMMON STOCK Purchase $4,550,000 +325,000 +11% $14.00 3,277,932 09 Nov 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOBT SERIES B CONVERTIBLE PREFERRED STOCK Conversion of derivative security -217,107 -100% 0 09 Nov 2021 COMMON STOCK 2,006,715 Direct F1
transaction IOBT SERIES C CONVERTIBLE PREFERRED STOCK Conversion of derivative security -75,267 -100% 0 09 Nov 2021 COMMON STOCK 946,217 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of preferred stock converted to common stock based on a conversion ratio that took into account interest that accrued since the date of issuance of the preferred stock and the price of the common stock sold to the underwriters in the IPO.
F2 Represents a purchase from the underwriters in the Issuer's initial public offering.